Treatment of chronic chikungunya arthritis with methotrexate: a systematic review

ConclusionThe available studies are limited, but taken together demonstrate sufficient efficacy to justify interest in the treatment of chronic chikungunya arthritis with MTX. The trials lacked rigorous study designs and used different treatment strategies and outcome measures. This systematic review underscores the need for randomized prospective, placebo‐controlled studies of MTX monotherapy in the treatment of chronic chikungunya arthritis.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Tags: Original Article Source Type: research